Spark Biomedical | Daniel Powell, CEO

Spark Biomedical's FDA-cleared Transcutaneous Auricular Neurostimulation (tAN™) is a non-invasive wearable treatment technology for opioid withdrawal relief.
Join Our Next Event
Partner with the leaders
shaping the future of
Medtech at LSI USA ‘26
March 16th - 20th, 2026
Waldorf Astoria, Monarch Beach
Speakers
Daniel Powell
Daniel Powell
CEO, Spark Biomedical